Cargando…

Body mass index and B‐lines on lung ultrasonography in chronic and acute heart failure

AIMS: Increased body mass index (BMI) is common in heart failure (HF) patients and is associated with lower levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP). We evaluated the influence of BMI on lung ultrasonography (LUS) findings indicative of pulmonary congestion (i.e. B‐lines) in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brainin, Philip, Claggett, Brian, Lewis, Eldrin F., Dwyer, Kristin H., Merz, Allison A., Silverman, Montane B., Swamy, Varsha, Biering‐Sørensen, Tor, Rivero, Jose, Cheng, Susan, McMurray, John J.V., Solomon, Scott D., Platz, Elke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261588/ https://www.ncbi.nlm.nih.gov/pubmed/32077268 http://dx.doi.org/10.1002/ehf2.12640

Ejemplares similares

Association between lung ultrasound findings and invasive exercise haemodynamics in patients with undifferentiated dyspnoea
por: Platz, Elke, et al.
Publicado: (2018)

Sex differences in congestive markers in patients hospitalized for acute heart failure
por: Espersen, Caroline, et al.
Publicado: (2021)

Left atrial inflow propagation velocity derived by color M-mode Doppler in acute heart failure
por: Johannessen, Øyvind, et al.
Publicado: (2022)

Postsystolic Shortening by Speckle Tracking Echocardiography Is an Independent Predictor of Cardiovascular Events and Mortality in the General Population
por: Brainin, Philip, et al.
Publicado: (2018)

Heart failure associated with imported malaria: a nationwide Danish cohort study
por: Brainin, Philip, et al.
Publicado: (2021)

Within trial comparison of survival time projections from short‐term follow‐up with long‐term follow‐up findings
por: Ferreira, João Pedro, et al.
Publicado: (2022)

Echocardiography and lung ultrasonography for the assessment and management of acute heart failure
por: Price, Susanna, et al.
Publicado: (2017)

Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
por: Sabe, Marwa A., et al.
Publicado: (2016)

Early Systolic Lengthening in Patients With ST‐Segment–Elevation Myocardial Infarction: A Novel Predictor of Cardiovascular Events
por: Brainin, Philip, et al.
Publicado: (2020)

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial
por: Wijkman, Magnus O., et al.
Publicado: (2020)

Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)

Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life
por: Vu, Katja, et al.
Publicado: (2021)

Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes
por: Wolsk, Emil, et al.
Publicado: (2022)

Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI
por: Wang, Xiaowen, et al.
Publicado: (2023)

Prognostic utility of diastolic dysfunction and speckle tracking echocardiography in heart failure with reduced ejection fraction
por: Hansen, Sune, et al.
Publicado: (2019)

Early systolic lengthening by speckle tracking echocardiography predicts outcome after coronary artery bypass surgery
por: Brainin, Philip, et al.
Publicado: (2021)

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration
por: Seferovic, Jelena P., et al.
Publicado: (2018)

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial
por: Vardeny, Orly, et al.
Publicado: (2019)

Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
por: Wolsk, Emil, et al.
Publicado: (2017)

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial
por: Vardeny, Orly, et al.
Publicado: (2016)

Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?
por: Modin, Daniel, et al.
Publicado: (2018)

Estimating the Lifetime Benefits of Treatments for Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2020)

Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction
por: Packer, Milton, et al.
Publicado: (2021)

Cardiac Time Intervals Measured by Tissue Doppler Imaging M‐mode: Association With Hypertension, Left Ventricular Geometry, and Future Ischemic Cardiovascular Diseases
por: Biering‐Sørensen, Tor, et al.
Publicado: (2016)

Right Ventricular Function Evaluated by Tricuspid Annular Plane Systolic Excursion Predicts Cardiovascular Death in the General Population
por: Modin, Daniel, et al.
Publicado: (2019)

SOLOIST‐WHF and updated meta‐analysis: sodium–glucose co‐transporter 2 inhibitors should be initiated in patients hospitalized with worsening heart failure
por: Docherty, Kieran F., et al.
Publicado: (2020)

Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
por: Modin, Daniel, et al.
Publicado: (2022)

Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF
por: Peikert, Alexander, et al.
Publicado: (2022)

Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)

Global longitudinal strain predicts incident atrial fibrillation and stroke occurrence after acute myocardial infarction
por: Olsen, Flemming Javier, et al.
Publicado: (2016)

Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose?
por: Kondo, Toru, et al.
Publicado: (2022)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
por: Vaduganathan, Muthiah, et al.
Publicado: (2020)

Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial
por: Bhatt, Ankeet S., et al.
Publicado: (2021)

Ideal Cardiovascular Health and the Prevalence and Severity of Aortic Stenosis in Elderly Patients
por: Sengeløv, Morten, et al.
Publicado: (2018)

Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment
por: Inciardi, Riccardo M., et al.
Publicado: (2022)

‘Hearts and minds’: association, causation and implication of cognitive impairment in heart failure
por: Cannon, Jane A, et al.
Publicado: (2015)

Talking to patients with heart failure about end of life
por: Campbell, Ross T., et al.
Publicado: (2018)

Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
por: Dewan, Pooja, et al.
Publicado: (2019)

Cardiopulmonary alterations by ultrasound in a patient with uncomplicated mixed malaria infection: a case report from the Amazon Basin
por: Wegener, Alma, et al.
Publicado: (2021)

The association between physical activity and cardiac performance is dependent on age: the Copenhagen City Heart Study
por: Joseph, Gowsini, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n63p42t7it66h8scj2fabhladg